HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data

Core Insights - HealthVerity has partnered with Recursion to license real-world data (RWD) to enhance clinical trial design and analytics [1][2] - Recursion will integrate HealthVerity's de-identified data covering over 340 million lives in the US into its data science and machine learning platforms, aiming to improve insights into patient populations and streamline clinical operations [2][4] - The partnership emphasizes the transformative potential of RWD in optimizing clinical trials and accelerating the development of novel therapeutics [3][4] Company Overview - HealthVerity is a leader in privacy-protected RWD exchange, facilitating connections and analysis of disparate patient data for healthcare and life sciences organizations [6] - Recursion is a clinical stage TechBio company focused on decoding biology to improve lives, utilizing its Recursion OS platform to generate extensive biological and chemical datasets [7] Strategic Goals - The collaboration aims to industrialize clinical development, reduce costs, and enhance trial design through in silico simulations and a patient-centric approach [2][4] - Recursion's integration of HealthVerity's data will strengthen its ability to predict patient responses and refine study designs, ultimately improving clinical trial enrollment [3][4]